News

The New York Times: Treating PTSD With MDMA? You Might Have Some Questions.

May 1, 2018 | News

Originally appearing here. Summary: The New York Times reports on the newly published results of MAPS’ U.S. Food and Drug Administration (FDA)-regulated clinical trial of MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder (PTSD) in...

MAPS Public Benefit Corporation

Our Mission
Who We Are
Careers
News
FAQ
Contact Us

1115 Mission Street
Santa Cruz, CA 95060-9989

Our Research

MDMA for PTSD
Expanded Access Program
Study Information
MDMA Brochure
Participate in Trials

Therapy Training

Overview
Application
Connect Portal

Sign Up for Therapy Training News

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.

Privacy Statement | Sitemap

News

The New York Times: Treating PTSD With MDMA? You Might Have Some Questions.

Recent Posts

Categories

MAPS Public Benefit Corporation

Our Research

Therapy Training

Sign Up for Therapy Training News

Success!